/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Dr. Dean Nachman received his MD degree from the Faculty of Medicine at the Hebrew University of Jerusalem, Israel, in 2010, graduating Suma Cum-Laude. He earned his specialty in Internal Medicine and Cardiology at Hadassah Medical Center. His scientific work focuses on the bio-convergence field, implementing engineering concepts in basic and translational research, from animal model studies to clinical trials, seeking remedies for unmet needs arising from his clinical experience. His main areas of clinical and scientific interest are heart failure and advanced hemodynamic monitoring, and he has established several research collaborations with renowned scientists. His research has been published in peer-reviewed papers and presented at national and international conferences, receiving several prestigious research grants. Since 2022 he leads the CV Technology Innovation Center comprised of a team of mechanical engineer, data scientists, MSc and MD students a lab manager and CV fellows.
Iatrogenic atrial-septal defect as a primary unloading strategy during acute myocardial infarction: insights from patients data based computational hemodynamic and a swine models
Event: Heart Failure 2024
Topic: Nonpharmacological Treatment
Session: New tools to detect and treat acute heart failure
